Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
患有急性髓系白血病 (AML) 且携带 IDH2-R172 突变的患者对强化化疗诱导治疗表现出独特的初始反应。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015324
Yisraeli Salman, Meira; Terry, Alexander R; Derkach, Andriy; Nemirovsky, David; Chin, Kuo-Kai; Valtis, Yannis K; Boussi, Leora; Spivey, Theresa; Xiao, Wenbin; Famulare, Christopher; Ciervo, Jenna; Rowe, Jacob M; Tallman, Martin S; Stein, Eytan M
